Difficulty: Medium
Average Score: 81%
Practice
Which of the following agents represents a relatively new class of drugs used in treating hypertension?
Correct answer
C
Rationale
The correct answer is C) Losartan. Losartan belongs to a relatively new class of drugs called angiotensin II receptor blockers (ARBs) used in treating hypertension. ARBs work by blocking the action of angiotensin II, a hormone that causes blood vessels to constrict, leading to lowered blood pressure.
A) Trandolapril is an ACE inhibitor, not a new class of drug. ACE inhibitors work by inhibiting the angiotensin-converting enzyme, reducing the production of angiotensin II.
B) Carvedilol is a beta-blocker, not a new class of drug. Beta-blockers work by blocking the effects of adrenaline, leading to decreased heart rate and blood pressure.
D) Moexipril is an ACE inhibitor, similar to Trandolapril, and not a new class of drug.
Understanding the different classes of drugs used in treating hypertension is crucial for healthcare professionals to make informed decisions when managing patients with high blood pressure. Knowing the mechanisms of action, side effects, and indications of each class helps in choosing the most appropriate treatment for individual patients based on their unique health needs and conditions.
A) Trandolapril is an ACE inhibitor, not a new class of drug. ACE inhibitors work by inhibiting the angiotensin-converting enzyme, reducing the production of angiotensin II.
B) Carvedilol is a beta-blocker, not a new class of drug. Beta-blockers work by blocking the effects of adrenaline, leading to decreased heart rate and blood pressure.
D) Moexipril is an ACE inhibitor, similar to Trandolapril, and not a new class of drug.
Understanding the different classes of drugs used in treating hypertension is crucial for healthcare professionals to make informed decisions when managing patients with high blood pressure. Knowing the mechanisms of action, side effects, and indications of each class helps in choosing the most appropriate treatment for individual patients based on their unique health needs and conditions.